Recent News

Latest GeoVax News

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
96
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is collaborating with the U.S. Naval Research Laboratory (USNRL) to develop...
Last modified on Continue reading
510
Participant Enrollment Completed for HVTN 114 Trial GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced that the HIV Vaccine Trials Network...
Last modified on Continue reading
459
Presentation to Focus on Development of Zika, Ebola and Lassa Fever Vaccines GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced that its...
Last modified on Continue reading
329
rogress in Multiple Vaccine Programs Including HIV, Zika, Lassa Fever, Malaria, Hepatitis B, and Cancer Immunotherapy   GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing...
Last modified on Continue reading
307
100% Single-Dose Protection Observed in Lethal Challenge Model GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced publication of its manuscript entitled...
Last modified on Continue reading